LGT Capital Partners LTD. Has $83.24 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

LGT Capital Partners LTD. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 158,115 shares of the healthcare conglomerate’s stock after selling 90,386 shares during the period. UnitedHealth Group makes up 2.5% of LGT Capital Partners LTD.’s investment portfolio, making the stock its 12th biggest holding. LGT Capital Partners LTD.’s holdings in UnitedHealth Group were worth $83,243,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Axiom Financial Strategies LLC bought a new stake in shares of UnitedHealth Group during the first quarter worth about $210,000. McGowan Group Asset Management Inc. increased its position in shares of UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after acquiring an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after acquiring an additional 60,300 shares in the last quarter. MAS Advisors LLC increased its position in shares of UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after acquiring an additional 45 shares in the last quarter. Finally, First Western Trust Bank bought a new stake in UnitedHealth Group in the 1st quarter worth about $875,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Trading Up 0.3 %

UnitedHealth Group stock traded up $1.60 during trading hours on Thursday, reaching $494.70. The stock had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The stock has a market cap of $456.08 billion, a PE ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The company has a fifty day simple moving average of $503.10 and a 200-day simple moving average of $518.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same period last year, the company posted $5.34 EPS. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 31.54%.

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Finally, Barclays started coverage on shares of UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 target price on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.